William Blair initiated coverage of Reneo Pharmaceuticals with an Outperform rating.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on RPHM:
- Reneo Pharmaceuticals files $300M mixed securities shelf
- Reneo Pharmaceuticals reports Q3 EPS (57c), consensus (57c)
- Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results
- Jefferies healthcare/biotech analysts hold an analyst/industry conference call
- Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences